Alzheimer's

In his resignation letter, Dr. Aaron Kesselheim calls it "probably the worst drug approval decision in recent U.S. history." An FDA official says the agency found the benefits outweighed the risks.

Aduhelm was recently approved by the FDA and quickly sparked controversy over its price and questionable benefits.

This is the first new drug approved for Alzheimer's disease since 2003. It's the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer's disease.

Researchers are looking to enroll 7,600 people for the study into whether computer-based cognitive training can prevent and even improve disorders such as dementia and Alzheimer’s disease.

An experimental medicine seems to ease symptoms of Fragile X syndrome, a genetic disorder that is the most common inherited cause of intellectual disabilities and autism.

Long-term care residents’ participation in the vaccination effort is clouded by a significant complication: More than half have cognitive impairment or dementia.

Researchers launched a major study of an experimental Alzheimer's drug this summer. They also learned a lot about how to protect participants who must make frequent visits to a medical center.

As the pandemic changes its day-to-day operations, a new executive director takes over the eleven-county agency.

Daisy Conant, 91, thrives off routine.One of her favorites is reading the newspaper with her morning coffee. But, lately, the news surrounding the…

Two new human studies back earlier hints that vaccines designed to prevent respiratory infections might also provide some protection against Alzheimer's disease.